In a groundbreaking development within the field of genetic research, a pan-Euro...
The exploration of childhood trauma has taken an unconventional turn, reaching i...
Astronomers, utilizing the innovative capabilities of the Large Binocular Telesc...
Sling Therapeutics has achieved a milestone in the development of its oral treat...
Umoja Biopharma has successfully closed a $100 million Series C funding round, m...
Regenxbio has struck a strategic partnership valued at $810 million with Japan’s...
AbbVie and Simcere Zaiming have announced an option-to-license agreement for the...
Incyte told JP Morgan attendees of plans for four launches in 2025, beginning wi...
Regenxbio will receive $110m upfront from Nippon Shinyaku and is eligible to get...
While US earnings grew in 2024, revenues in China were hurt by ongoing investiga...
Insmed is set to challenge the Duchenne muscular dystrophy (DMD) treatment space...
Be Biopharma has secured $92m in a Series C financing round to advance its clini...
Eli Lilly has received approval from the US FDA for Omvoh to treat moderately to...
AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflam...
At the JP Morgan Healthcare Conference 2025, Charles River CEO blamed low client...
